The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
